Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash (MYL, SLXP, HITK, AKRX)

Below are the top drugs-generic stocks on the NASDAQ in terms of cash.

Mylan Inc (NASDAQ: MYL) had $641.03 million in total cash for the latest quarter. Meanwhile, MYL's total debt stood at $5.41 billion.

Salix Pharmaceuticals Ltd (NASDAQ: SLXP) had $491.47 million in total cash and $319.99 million in total debt for the latest quarter.

Hi-Tech Pharmacal Co Inc (NASDAQ: HITK) had $45.19 million in total cash and $756.00 thousand in total debt for the latest quarter.

Akorn Inc (NASDAQ: AKRX) had $9.50 million in total cash for the latest quarter. AKRX's total debt for the same period amounted to $5.85 million.

Trading Ideas.